(Updated - January 23, 2026 6:20 AM EST)

Leerink Partners analyst Andrew Berens upgraded Relmada Therapeutics Inc (NASDAQ: RLMD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE